Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Bristol-Myers Squibb: Q4 Earnings Insights

 

Bristol-Myers Squibb (NYSE:BMY) reported its Q4 earnings results on Friday, February 4, 2022 at 06:59 AM.

Here's what investors need to know about the announcement.

Also check this: Executives Buy More Than $28M Of 4 Stocks

Earnings

Bristol-Myers Squibb beat estimated earnings by 1.67%, reporting an EPS of $1.83 versus an estimate of $1.80, which did not surprise analysts.

Revenue was up $917.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08, which was followed by a 1.13% increase in the share price the next day.

Here's a look at Bristol-Myers Squibb's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate 1.92 1.91 1.82 1.41
EPS Actual 2 1.93 1.74 1.46
Revenue Estimate 11.58B 11.33B 11.11B 10.73B
Revenue Actual 11.62B 11.70B 11.07B 11.07B

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Guidance

Bristol-Myers Squibb management provided guidance for their next quarter, expecting earnings between $7.65 and $7.95 per share for the next quarter.

This represents a 326.23% in quarter-over-quarter growth for Bristol-Myers Squibb, a bullish signal to many investors.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.